Invention Grant
- Patent Title: Treatment of relapsed and/or refractory solid tumors and non-Hodgkin's lymphomas
-
Application No.: US16709874Application Date: 2019-12-10
-
Publication No.: US10849898B2Publication Date: 2020-12-01
- Inventor: Jiangchun Xu , Robert Cho , Aaron Nguyen
- Applicant: CELGENE QUANTICEL RESEARCH, INC.
- Applicant Address: US CA San Diego
- Assignee: CELGENE QUANTICEL RESEARCH, INC.
- Current Assignee: CELGENE QUANTICEL RESEARCH, INC.
- Current Assignee Address: US CA San Diego
- Agency: Foley & Lardner LLP
- Main IPC: A61K31/513
- IPC: A61K31/513 ; A61K31/5685 ; A61K31/551 ; A61K31/5377 ; A61K31/436 ; A61K31/7048 ; A61P35/00 ; A61K31/357 ; C07D401/14 ; C07D401/04 ; C07D405/14
Abstract:
Methods are provided for the treatment of relapsed and/or refractory solid tumors (including neuroendocrine carcinomas (NEC)) and non-Hodgkin's lymphomas (NHLs) and the like, using substituted heterocyclic derivative compounds and pharmaceutical compositions comprising compounds useful for the inhibition of lysine specific demethylase-1 (LSD-1).
Public/Granted literature
- US20200113905A1 TREATMENT OF RELAPSED AND/OR REFRACTORY SOLID TUMORS AND NON-HODGKIN'S LYMPHOMAS Public/Granted day:2020-04-16
Information query
IPC分类:
